Ozempic may soon be hard to find in Canada as supplier cites shortage

A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, the manufacturer said Friday.

Novo Nordisk said it is experiencing a temporary supply disruption with the Ozempic its one-millagram injection pen.

It said the shortage is due to a combination of global supply constraints and increased demand for the drug.

Health Canada said intermittent shortages are expected from late August to early October.

Both Health Canada and Novo Nordisk say the 0.25 mg and 0.5 mg doses of Ozempic remain available for patients with Type 2 diabetes.

They say pharmacists are encouraged to limit refill prescriptions to a 30-day supply.

More to come

Advertisement

More on Canada

&copy 2023 The Canadian Press

Lifestyle

Articles You May Like

Podcast: How to think about social media
He Thought He’d Be the First Black Man in Space — Now the 90-Year-Old’s Dream is Coming True
This Song Explains The Laws of Success That Apply To EVERYONE ON EARTH!
How to Wake Up from the Painful Trance of Unworthiness
How I Found the Good Within the Difficult

Leave a Reply

Your email address will not be published. Required fields are marked *